Table: begin end state 1 29 cytoplasmic 30 41 non-cytoplasmic 42 55 transmembrane 56 68 non-cytoplasmic 69 90 transmembrane 91 101 cytoplasmic 102 126 transmembrane 127 130 non-cytoplasmic 131 157 transmembrane 158 175 cytoplasmic 176 196 transmembrane 197 201 non-cytoplasmic 202 221 transmembrane 222 259 cytoplasmic 260 284 transmembrane 285 295 non-cytoplasmic 296 315 transmembrane 316 325 cytoplasmic 326 345 transmembrane 346 351 non-cytoplasmic 352 373 transmembrane 374 391 cytoplasmic 392 412 transmembrane 413 418 non-cytoplasmic 419 439 transmembrane 440 445 cytoplasmic
Input: >WP_050464670.1 NCBI__GCF_001189915.1:WP_050464670.1 MKDVALNPGTDGLGQPPAAVAHDAKVGRRAVIAASTGNALEWYDFTVYALFAVYIGQNFF KNDNPTVQLMGSFMAFGLGYVARPLGALLLGSYGDRAGRKAALTMTIMLMALGTLLIAIA PPYAAIGIGAPLLIVCGRVLQGFSAGGEIGGATAFLVEHAPPEKKGQYASWLQASMGISN VLGALVATIVTTVFTVDQIGEWAWRIPFIIGLAIAPVGLWMRKTLDETPHFKLEEARMKK SGVEKKTPLLQVIRECPKQLLAGFGLSVLWAAGPYSLIIFMPIYVQKTMGFASSQAFLAA FIGNFFLIGGCVFSGTLSDKLGRRTVLRIGAILLLVGVYPLMMWLQASHTTATLIIVQSL FCAMISMFVGVAPSALSEIFPTAVRSSGMSLSYNTAVTLLGGFAPAILTWITYTTGVAFA PALYVMVAAVIALIAISVLPEASKD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server